Niagen Bioscience
NAGE
78 hedge funds and large institutions have $45.1M invested in Niagen Bioscience in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 16 closing their positions.
119% more call options, than puts
Call options by funds: $379K | Put options by funds: $173K
75% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 16
40% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 15
16% more funds holding
Funds holding: 67 → 78 (+11)
4.45% more ownership
Funds ownership: 17.43% → 21.88% (+4.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $45.7M → $45.1M (-$560K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$7.41M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.91M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.22M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.13M |
| 5 |
JP Morgan Chase
New York
|
+$836K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.31M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$902K |
| 3 |
Jane Street
New York
|
-$687K |
| 4 |
HF
HRT Financial
New York
|
-$455K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$422K |
NAGE Hedge Fund Activity: Q2 2024 in Review
78 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q2 2024, worth a combined $45.1M — down 1.2% from $45.7M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new NAGE positions and 16 closed out — a net gain of 12 holders — while 21 added to existing stakes and 15 trimmed.
The largest buyer was BlackRock, adding an estimated $7.41M. The largest seller was Millennium Management, cutting an estimated $1.31M.
- 78 institutional investors held Niagen Bioscience (NAGE) as of Q2 2024, up from 67 in Q1 2024.
- Funds reported $45.1M of Niagen Bioscience stock for Q2 2024, down 1.2% quarter-over-quarter.
- 28 funds opened new Niagen Bioscience positions in Q2 2024 and 16 closed out, a net change of +12 holders.
- The largest Niagen Bioscience buyer in Q2 2024 was BlackRock, an estimated $7.41M added.
- The largest Niagen Bioscience seller in Q2 2024 was Millennium Management, an estimated $1.31M sold.
Based on aggregated 13F filings for Q2 2024.